Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|July 8, 2022
PRMT5 activates AKT via methylation to promote tumor metastasisLei Huang, Xiao-Ou Zhang, Esteban J Rozen, et al.Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma TherapyMyrthala Moreno-Smith, Anna Lakoma, Zaowen Chen, et al.Cancer Letters|July 1, 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaAnneleen Beckers, Gert Van Peer, Daniel R Carter, et al.Molecular Cancer Therapeutics|March 26, 2026
Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk NeuroblastomaGriffin I Kane, Miranda B Diaz-Infante, Kim Wigglesworth, et al.Oncotarget|December 8, 2017
EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastomaWenjing Sun, Yesenia Rojas, Hao Wang, et al.Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.Cancer Research|October 17, 2015
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in NeuroblastomaYuting Sun, Jessica L Bell, Daniel Carter, et al.Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.Pageof 4